Novacyt launches molecular HPV service to its NOVAPREP® customers

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics has launched a molecular HPV (Human Papillomavirus) service for all its customers who currently use its next generation NOVAprep® liquid-based cytology platform for cervical cancer screening. Download press release

Visit Page

Novacyt and Leica Biosystems launch NOVAPREP® in China

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics and Leica Biosystems, a leading supplier to the pathology market, today announce the start of the sales and marketing programme for the launch of the NOVAprep® platform in China. Download press release

Visit Page

Novacyt appoints new Group Commercial Director

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release

Visit Page